Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease
Research output: Contribution to journal › Journal article › Research › peer-review
Alpha-1 antitrypsin deficiency is an inherited disorder that can cause lung disease. People who smoke are more seriously affected and have a greater risk of dying from the disease.
Original language | English |
---|---|
Journal | Cochrane Database of Systematic Reviews |
Issue number | 7 |
Pages (from-to) | CD007851 |
ISSN | 1361-6137 |
DOIs | |
Publication status | Published - 1 Jan 2010 |
ID: 34080892